Hypotension and blood loss Sir, I read with interest Dr Wittmann's paper 'Blood loss associated with uncemented total hip replacement: hypotension does not affect blood loss' (April JRSM, p 213) and would like to make the following points.
Firstly, there are a number of criticisms of the construction of this study which raise doubts about the validity of the statistical analysis. There is no mention of the cause of the hypotension in the 27 test patients and this could, therefore, have been caused by an independent factor which also affected the blood loss. In addition, the difference in size of the two groups makes adequate analysis of Student's t test questionable, especially as the cases were selected rather than randomized and the spread of values for blood loss unlikely to be of normal distribution.
Secondly, Dr Wittmann states that he intended to undertake a randomized prospective study to test his hypothesis but, as his retrospective data failed to show a significant advantage, he felt this was unethical. Surely the whole reason for undertaking a prospective, well documented study is that retrospective analysis-of data is not capable, as this study demonstrates, of providing the answer. Not to undertake a well controlled study simply because a pilot study of inferior validity failed to provide the required results is against the basic principles of research. Unfortunately, a large amount of past clinical practice has been based on such retrospective studies, much of which is now being questioned by properly controlled trials.
Thirdly, the author seems to indicate that reduction in blood loss is the main reason for hypotension during orthopaedic operations and I would disagree with this. The risks associated with lowering the blood pressure in elderly people are far greater than those associated with blood loss and transfusion. It therefore seems illogical to lower the blood pressure solely for the purpose of reducing blood loss. Hypotension is indicated when a reduction in bleeding at the operation site is required to improve exposure, thereby permitting delicate surgery to be undertaken in a bloodless field. It is for this reason that its use is popular in neurosurgical procedures both on the spine and intracranially. In total hip replacement a bloodless field is not necessary for the adequate performance of the operation and, therefore, the use of hypotension in this type of surgery is not required, regardless of its effect on blood loss.
Finally, despite the above criticisms, I would like to add my support to the final conclusion drawn by Dr Wittmann. Hypotensive anaesthesia should not be used in patients undergoing total hip replacement. It is very easy for a surgeon during a difficult operation, when faced with a bloodier than average operation site, to blame the anaesthetist rather than his own surgical technique, and I feel this practice should be discouraged. I do not, however, think that the data contained in this paper are of sufficient quality to substantiate this conclusion.
G P WILDE

Spinal Research Fellow
Harlow Wood Orthopaedic Hospital, nr Mansfield, Notts
*Dr Wittmann replies below:
Sir, I did, in fact, suggest the reason for the hypotension occurring in the 27 patients. It is unlikely that it could have been caused by an independent factor which could have affected the blood loss as all of the patients were treated in exactly the same way.
As to the size of the two groups, the first draft of my manuscript submitted to the JRSM compared the 27 hypotensive patients with 27 other patients in the series who were carefully matched. The referee for the JRSM commented that: 'The method of matching patients between hypotensive and normotensive groups introduces bias ... the correct comparison would be between the 27 hypotensive patients and the 216 normotensive patients'. Interestingly, the same results as reported were found in the matched groups.
Mr Wilde states that: 'Not to undertake a well controlled study ... is against the basic principles of research'. I feel strongly, however, that undertaking a trial in which 'required results' are necessary is very much against the basic principles of research.
With my knowledge of the retrospective findings, it would have been wrong of me to put a case to the hospital ethical committee who would have been duty-bound to refuse permission for a randomized trial. I am surprised that Mr Wilde should suggest that such a trial be conducted as he states that, 'lowering the blood pressure in elderly patients is dangerous', and that 'Hypotensive anaesthesia should not be used in patients undergoing total hip replacement' (no evidence or reasons given). To the contrary, hypotensive anaesthesia has been advocated in many papers (I referred to 5 in my paper) as a useful means of reducing blood loss in THR surgery.
Finally, I certainly did not suggest that reduction in blood loss is the main reason for hypotension during THR but rather that, as there was no advantage in terms of blood loss, hypotension should be strictly avoided.
F W WITTMANN
Consultant Anaesthetist East Surrey Hospital, Redhill
Porokeratosis and immunosuppression
Sir, We were interested to read the case report by Tatnall and Sarkany who describe porokeratosis of Mibelli in an immunocompromised patient (March JRSM, p 180). They cite several other reports in the literature and conclude that there is an association between porokeratosis and immunosuppression, although it seems to be rare.
We have seen a 44-year·old Caucasian woman with systemic lupus erythematosus of 20 years' duration and mild renal failure due to membrano proliferative glomerulonephritis, who has been on prednisolone for 10 years and has recently developed several biopsy-confirmed lesions of porokeratosis of Mibelli on her arms. In the last 6 years she has also developed multiple viral warts on her hands, arms and legs, herpes zoster of the third thoracic dermatome, a basal cell carcinoma on her nose, a keratoacanthoma on her left upper eyelid and has had a hysterectomy for in situ carcinoma of the cervix.
This case not only provides further anecdotal evidence of an association between porokeratosis and immunosuppression, but also emphasizes the importance of immunocompetence in protecting against skin neoplasms and infections. The most common illnesses have to do with the gastrointestinal tract and the skin. To name some, these include diarrhoea, nausea, retching and vomiting. Others are itching, reddening of the skin and urticarial wheals. In some, urinary frequency becomes a problem.
C E H GRATTAN
Department of Dermatology
The principal characteristic, separating out the organic causes, is early onset. This onset occurs before the radiation effect can possibly be a factor. It is found increasingly in countries where liability suits are common (e.g. USA) and less commonly in countries such as Canada. It stems from a fear of a liability suit so that the physician, in order to help protect himself from a lawsuit, is required to tell the patient about possible side effects. These are usually detailed. It matters little that he points out that these side effects will not occur until weeks later. Diarrhoea most commonly begins with the first treatment.
One may refer to these as 'tortogenic illnesses'. Clearly, they are brought on by the physician's information to the patient and therefore may justifiably be called iatrogenic.
As with other iatrogenic illnesses, it produces misery for the patient, complicates other diseases, and could be avoided but only at the risk of a less complete 'informed consent'. It makes my practice of medicine less satisfying since I know it harms my patient. The black rat, the vector (via its fleas) of the great European bubonic plague outbreaks, reached the Near East and Europe some time before the first century AD, judging from recently reported remains in an Egyptian Red Sea port and in central Europa'. But the silence of all ancient authors, including Aristotle, makes it unlikely this happened until late antiquity. I have suggested that the black rat arrived from India after the discovery of the monsoon in the second or first century BC. This permitted direct voyages between Graeco-Roman Egypt and India, and a massive volume of trade between India and the Roman Empire, with ample opportunities for the 'ship-rat' (as this species is called) to reach the Near East and Europe".
'Rat-borne' diseases are therefore unlikely to have occurred in Old Testament times. The 'plague of the Philistines' was examined in great detail by Shrewsbury", In accord with Josephus's ancient interpretation (Antiquities 6:1), he showed that both the circumstances of the epidemic and the nature of the symptoms perfectly fitted bacillary dysentery, which can lead to piles -the 'emerods' (haemorrhoids) of the Authorised Version, the best translation of the Hebrew word opalim. The biblical concordance leads one to Psalms 78:66, where the Lord 'smote his enemies in the hinder parts'. The 'mice' that also afflicted the Philistines were not vectors but crop pests; they were 'mice that mar the land' (1 Sam. 6:5). They may have prepared the way for the epidemic by producing food shortage", Plague is carried by many wild rodent species not closely associated with man. In Manchuria in 1910--11, people were infected from a wild rodent source, the disease became pneumonic, and it spread rapidly by human contact.'. Such a 'sylvatic' plague episode is not inconceivable in the ancient Near East.
